|
GENERAL PEDIATRICS DRUG INFORMATION
Acetylsalicylic Acid
Antiplatelet
Antiplatelet therapy (including Kawasaki Disease)
PO:
3-5 mg/kg (minimum: 20 mg) (usual maximum: 80 or 325 mg) Q24H
Availability: Round dose to nearest 1/4 tab
Supplied as:
Chewable tablets: 80 mg
Tablets: 325, 650 mg
Enteric coated tablets: 81, 325, and 650 mg
Updated: 12/21/2022
Disclaimer: This document has been created specifically for Hamilton Health Sciences (HHS) to use for its own patients and the information contained herein may not be applicable or relevant to other health care organizations. This document is for informational purposes only and is not intended to be a substitute for medical or clinical advice from a qualified health care professional. HHS makes no representations or warranties as to the accuracy of the information. This material is current only to the date listed. This material is the intellectual property of HHS and may not be shared, duplicated, or distributed further without the consent of HHS. HHS assumes no liability for the use of this information by the recipient.
| |